← Eichor
Study identifier: NCT04924712 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

INS, B Cells and Microbiota

Condition: Microbiota · B-lymphocytes · Glomerulosclerosis  ·  Sponsor: Nantes University Hospital

PhaseN/A
Planned participants30
Who can joinAll sexes, 12 Years to no upper limit
Healthy volunteersNo

About this study

Idiopathic nephrotic syndrome (NIS) is a clinical entity defined by the association of selective albuminuria, hypoalbuminemia, and nonspecific glomerular lesions (lesions minimal glomerular (LGM) or segmental and focal hyalinosis (HSF). The complication of this kidney disease is the progression towards chronic renal failure and in case of kidney transplantation, its immediate recurrence on the graft . The origin of this syndrome is unknown but a number of clinical observations tend to show an involvement of immune system. A link has been highlighted between atopy, diet and nephrotic flare-ups. The speed of recurrence of this initial disease on the graft and the observation of remissions obtained after treatment by plasma exchange or immunoadsorptions support the presence of a pathogenic plasma factor. Anti-CD20 treatments depleting B lymphocytes has made it possible to favorably treat a number of patients. Dysfunction of regulatory T cells has also been shown in SNI patients. This modification seems linked to allergies and could be due to an aberrant microbiota. The hypothesis of causality between dysbiosis, alteration lymphocyte and triggering of an SNI was mentioned recently. Two studies have shown intestinal dysbiosis in pediatric SNI/LGM, with reduction of T circulating regulators

This description comes directly from the study's public registry record.

Talk to the study team

Christophe Masset  ·  +33 2 76 64 39 61  ·  christophe.masset@chu-nantes.fr

Always discuss trial participation with your own doctor first.

Locations (2)

Nantes University HospitalNantes, Loire-Atlantique, FranceRecruiting
Departemental Hospital CenterLa Roche-sur-Yon, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04924712